Global tax agreement could prompt Novo Nordisk to take tax payments elsewhere
A global tax agreement involving a 15 percent minimum tax rate may cause Novo Nordisk to relocate its annual tax payments away from Denmark, for example to the US.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Novo Nordisk may relocate a large portion of its DKK 8.2bn (USD 1.34bn) Danish tax payments, for example to the US, once the global agreement for a minimum tax rate is passed, according to Danish media Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk launches smart insulin pen in Denmark
For subscribers
Novo Nordisk prepares to launch diabetes tablet in India
For subscribers
.jpg&w=384&q=75)
